• Needham & Company LLC Reiterates Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP)

    المصدر: Buzz FX / 06 نوفمبر 2024 08:48:16   America/New_York


    Needham & Company LLC Reiterates Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP) Written by MarketBeat November 6, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "buy" rating res
    Read more...
شارك على،